Kiora Gross Profit from 2010 to 2025

KPRX Stock

USD 3.69 0.10 2.64%

Kiora Pharmaceuticals Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Kiora Pharmaceuticals makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2016-06-30

Previous Quarter

16 M

Current Value

2.1 K

Quarterly Volatility

3.6 M

Covid

Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 84.2 K, Selling General Administrative of 4.8 M or Other Operating Expenses of 10.3 M, as well as many indicators such as Price To Sales Ratio of 16 K, Dividend Yield of 0.0 or PTB Ratio of 0.39. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Kiora Pharmaceuticals Correlation against competitors.

For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

Latest Kiora Pharmaceuticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Kiora Pharmaceuticals over the last few years. Gross profit is a required income statement account that reflects total revenue of Kiora Pharmaceuticals minus its cost of goods sold. It is profit before Kiora Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Kiora Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (5.14 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Kiora Gross Profit Regression Statistics

	Arithmetic Mean	(138,624)
	Geometric Mean	805,287
	Coefficient Of Variation	(1,372)
	Mean Deviation	1,352,100
	Median	669,259
	Standard Deviation	1,901,333
	Sample Variance	3.6T
	Range	6.7M
	R-Value	(0.66)
	Mean Square Error	2.2T
	R-Squared	0.44
	Significance	0.01
	Slope	(264,226)
	Total Sum of Squares	54.2T

Kiora Gross Profit History

	2025	-3.4 M
	2024	-3.6 M
	2023	-4 M
	2022	-134 K
	2021	-227.3 K
	2020	-188.2 K
	2019	2.7 M

Other Fundumenentals of Kiora Pharmaceuticals

Gross Profit Margin

Kiora Pharmaceuticals Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Intangible Assets	Net Tangible Assets	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Property Plant Equipment	Capital Stock	Long Term Debt	Short Long Term Debt
Total Assets		0.93	-0.63	-0.86	0.28	0.47	-0.88	0.75	-0.49	0.48	0.46	0.64	0.76	0.71	0.8	0.78	0.56	-0.68	-0.18	-0.18
Total Stockholder Equity	0.93		-0.65	-0.81	0.28	0.49	-0.99	0.76	-0.56	0.5	0.41	0.46	0.72	0.56	0.74	0.73	0.46	-0.65	-0.25	-0.25
Net Debt	-0.63	-0.65		0.28	-0.16	-0.04	0.65	-0.94	0.65	-0.6	-0.45	0.02	-0.23	-0.02	-0.3	-0.34	-0.1	0.04	-0.13	-0.13
Retained Earnings	-0.86	-0.81	0.28		-0.11	-0.75	0.74	-0.49	0.35	-0.26	-0.31	-0.75	-0.92	-0.81	-0.85	-0.85	-0.81	0.87	0.46	0.46
Accounts Payable	0.28	0.28	-0.16	-0.11		-0.04	-0.27	0.17	-0.01	-0.05	0.38	0.15	-0.14	0.02	-0.07	-0.16	-0.02	0.0	0.14	0.14
Net Receivables	0.47	0.49	-0.04	-0.75	-0.04		-0.43	0.32	-0.25	-0.01	0.08	0.67	0.72	0.65	0.5	0.51	0.89	-0.61	-0.72	-0.72
Total Liab	-0.88	-0.99	0.65	0.74	-0.27	-0.43		-0.74	0.56	-0.49	-0.34	-0.38	-0.65	-0.49	-0.68	-0.68	-0.37	0.61	0.17	0.17
Total Current Assets	0.75	0.76	-0.94	-0.49	0.17	0.32	-0.74		-0.53	0.61	0.48	0.17	0.44	0.2	0.44	0.49	0.36	-0.2	-0.09	-0.09
Short Term Debt	-0.49	-0.56	0.65	0.35	-0.01	-0.25	0.56	-0.53		-0.3	-0.29	-0.16	-0.31	-0.21	-0.3	-0.31	-0.2	0.26	0.14	0.14
Common Stock	0.48	0.5	-0.6	-0.26	-0.05	-0.01	-0.49	0.61	-0.3		0.37	-0.18	0.33	-0.04	0.37	0.4	0.0	0.1	-0.05	-0.05
Current Deferred Revenue	0.46	0.41	-0.45	-0.31	0.38	0.08	-0.34	0.48	-0.29	0.37		0.02	0.05	0.01	0.01	0.01	0.08	-0.02	-0.17	-0.17
Intangible Assets	0.64	0.46	0.02	-0.75	0.15	0.67	-0.38	0.17	-0.16	-0.18	0.02		0.66	0.96	0.63	0.57	0.77	-0.76	-0.31	-0.31
Net Tangible Assets	0.76	0.72	-0.23	-0.92	-0.14	0.72	-0.65	0.44	-0.31	0.33	0.05	0.66		0.76	0.94	0.96	0.8	-0.84	-0.51	-0.51
Deferred Long Term Liab	0.71	0.56	-0.02	-0.81	0.02	0.65	-0.49	0.2	-0.21	-0.04	0.01	0.96	0.76		0.73	0.7	0.74	-0.83	-0.3	-0.3
Net Invested Capital	0.8	0.74	-0.3	-0.85	-0.07	0.5	-0.68	0.44	-0.3	0.37	0.01	0.63	0.94	0.73		0.97	0.62	-0.84	-0.3	-0.3
Net Working Capital	0.78	0.73	-0.34	-0.85	-0.16	0.51	-0.68	0.49	-0.31	0.4	0.01	0.57	0.96	0.7	0.97		0.66	-0.8	-0.3	-0.3
Property Plant Equipment	0.56	0.46	-0.1	-0.81	-0.02	0.89	-0.37	0.36	-0.2	0.0	0.08	0.77	0.8	0.74	0.62	0.66		-0.66	-0.62	-0.62
Capital Stock	-0.68	-0.65	0.04	0.87	0.0	-0.61	0.61	-0.2	0.26	0.1	-0.02	-0.76	-0.84	-0.83	-0.84	-0.8	-0.66		0.36	0.36
Long Term Debt	-0.18	-0.25	-0.13	0.46	0.14	-0.72	0.17	-0.09	0.14	-0.05	-0.17	-0.31	-0.51	-0.3	-0.3	-0.3	-0.62	0.36		1.0
Short Long Term Debt	-0.18	-0.25	-0.13	0.46	0.14	-0.72	0.17	-0.09	0.14	-0.05	-0.17	-0.31	-0.51	-0.3	-0.3	-0.3	-0.62	0.36	1.0

Click cells to compare fundamentals

About Kiora Pharmaceuticals Financial Statements

Kiora Pharmaceuticals investors use historical fundamental indicators, such as Kiora Pharmaceuticals' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	-3.6 M	-3.4 M
Gross Profit Margin	(14.04)	(14.75)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GM	General Motors
C	Citigroup

Additional Tools for Kiora Stock Analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC